AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32826776 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally tailored pragmatic implementation strategies
Number of subjects: 74
Study 35319299 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (fraction in inspired oxygen: 0.10)
Number of subjects: 16
Study 35319299 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxia (fraction in inspired oxygen: 0.50)
Number of subjects: 16
Study 35319299 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 16
Study 33316435 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (45 min, 3 times/week at 65% to 80% heart rate reserve)
Number of subjects: 36
Study 33316435 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 36
Study 33316435 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 36
Study 32335860 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongguan Capsules (4.5 g/d) for 3 months
Number of subjects: 400
Study 32335860 — intervention group
Group type: COMPARATOR
Intervention: Standard anti-platelet, anti-coagulation and lipid-decreasing treatments
Number of subjects: 400
Study 35792926 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week, multimodal, bi-weekly exercise intervention (EG)
Number of subjects: 43
Study 35792926 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 43
Study 32418174 — intervention group
Group type: EXPERIMENTAL
Intervention: Nux Vomica Capsule (NVC, 0.4 g, thrice daily) for 30 days
Number of subjects: 19
Study 34773837 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume hemodiafiltration (HDF)
Number of subjects: 9
Study 34773837 — intervention group
Group type: COMPARATOR
Intervention: High flux hemodialysis (hf‐HD)
Number of subjects: 9
Study 32727433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status assessment (stunting and wasting)
Number of subjects: 298
Study 32727433 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary diversity (mean number of food groups consumed)
Number of subjects: 298
Study 32727433 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with stunting
Number of subjects: 298
Study 32727433 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with wasting
Number of subjects: 298
Study 35717148 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 90
Study 35717148 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB)
Number of subjects: 90
Study 35717148 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (Control)
Number of subjects: 90
Study 32219499 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise programme
Number of subjects: 141
Study 32219499 — intervention group
Group type: COMPARATOR
Intervention: Control group (equal attention)
Number of subjects: 141
Study 36243698 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial repellent intervention
Number of subjects: 0
Study 36243698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33634794 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Atkins Diet (mAD)
Number of subjects: 60
Study 33634794 — intervention group
Group type: COMPARATOR
Intervention: Low Glycemic Index Treatment (LGIT)
Number of subjects: 60
Study 35426351 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental exercise group (EG)
Number of subjects: 0
Study 35426351 — intervention group
Group type: COMPARATOR
Intervention: Control no-exercise group (CG)
Number of subjects: 0
Study 32467089 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic sphincter augmentation (MSA)
Number of subjects: 152
Study 32467089 — intervention group
Group type: COMPARATOR
Intervention: Two times a day proton pump inhibitor (PPI)
Number of subjects: 152
Study 33125448 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Therapy (MST)
Number of subjects: 60
Study 33125448 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive Therapy (ECT) - Bitemporal (BT)
Number of subjects: 60
Study 33125448 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive Therapy (ECT) - Right Unilateral (RUL)
Number of subjects: 60
Study 36250434 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial alternating current stimulation (tACS) at 10 HZ, 1 mA for 15 minutes over 10 sessions.
Number of subjects: 45
Study 36250434 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group).
Number of subjects: 45
Study 36250434 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 45
Study 33447937 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.2 mg
Number of subjects: 0
Study 33447937 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy
Number of subjects: 0
Study 35354411 — intervention group
Group type: EXPERIMENTAL
Intervention: MSB11456
Number of subjects: 685
Study 35354411 — intervention group
Group type: EXPERIMENTAL
Intervention: US-licensed tocilizumab
Number of subjects: 685
Study 35354411 — intervention group
Group type: EXPERIMENTAL
Intervention: EU-approved tocilizumab
Number of subjects: 685
Study 33486982 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback on CVD risk and discussion of risk reduction
Number of subjects: 40
Study 33486982 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention
Number of subjects: 40
Study 33486982 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 40
Study 32742206 — intervention group
Group type: EXPERIMENTAL
Intervention: Self Photo (SP)
Number of subjects: 88
Study 32742206 — intervention group
Group type: EXPERIMENTAL
Intervention: Assistive Device (AD)
Number of subjects: 88
Study 32742206 — intervention group
Group type: EXPERIMENTAL
Intervention: Other Party (OP)
Number of subjects: 88
Study 34942508 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural dexterity curriculum (not specified dosage or duration)
Number of subjects: 266
Study 33994252 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (n=100) focusing on healthy exercise and diet
Number of subjects: 204
Study 33994252 — intervention group
Group type: COMPARATOR
Intervention: Health and Wellness Intervention (n=104) with no mention of exercise or diet behavior changes
Number of subjects: 204
Study 32879331 — intervention group
Group type: EXPERIMENTAL
Intervention: AI model for predicting CHD risk
Number of subjects: 1273
Study 34813959 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (HA) coated pedicle screws
Number of subjects: 24
Study 34813959 — intervention group
Group type: COMPARATOR
Intervention: Control pedicle screws without HA (Ti6Al4V)
Number of subjects: 24
Study 34331010 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 800 mg
Number of subjects: 48
Study 34331010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 35818044 — intervention group
Group type: EXPERIMENTAL
Intervention: multimodal psychomotor program [EG1]
Number of subjects: 51
Study 35818044 — intervention group
Group type: EXPERIMENTAL
Intervention: combined program (multimodal psychomotor program + whole‐body vibration program) [EG2]
Number of subjects: 51
Study 35818044 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 51
Study 33864831 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical systolic blood pressure (SBP)
Number of subjects: 100
Study 33864831 — intervention group
Group type: EXPERIMENTAL
Intervention: Body surface area (BSA)
Number of subjects: 100
Study 33864831 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 h SBP
Number of subjects: 100
Study 33864831 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily SBP
Number of subjects: 100
Study 33864831 — intervention group
Group type: EXPERIMENTAL
Intervention: Nightly SBP
Number of subjects: 100
Study 32631305 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 12
Study 32631305 — intervention group
Group type: COMPARATOR
Intervention: PSV1
Number of subjects: 12
Study 32631305 — intervention group
Group type: COMPARATOR
Intervention: PSV2
Number of subjects: 12
Study 37064289 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Yoga Intervention (OYI)
Number of subjects: 72
Study 37064289 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga cum Ayurveda Intervention (OYAI)
Number of subjects: 72
Study 37064289 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 72
Study 33249081 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambler Therapy
Number of subjects: 50
Study 33249081 — intervention group
Group type: COMPARATOR
Intervention: TENS
Number of subjects: 50
Study 33785226 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 247
Study 33785226 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol/Diclofenac
Number of subjects: 247
Study 33785226 — intervention group
Group type: COMPARATOR
Intervention: Control (no pharmacologic treatment)
Number of subjects: 247
Study 35320165 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands parallel to trunk (Group C)
Number of subjects: 60
Study 35320165 — intervention group
Group type: COMPARATOR
Intervention: Hands above head (Group A)
Number of subjects: 60
Study 35320165 — intervention group
Group type: COMPARATOR
Intervention: Hands behind head (Group B)
Number of subjects: 60
Study 35320165 — intervention group
Group type: COMPARATOR
Intervention: Hands on chest (Group D)
Number of subjects: 60
Study 33000120 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaboost model (machine learning algorithm)
Number of subjects: 201
Study 33000120 — intervention group
Group type: COMPARATOR
Intervention: Knosp grade and postoperative immediate morning serum cortisol (PoC)
Number of subjects: 201
Study 33000120 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative 24-hour urine free cortisol, PoC, and age
Number of subjects: 201
Study 33000120 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning models (general)
Number of subjects: 201
Study 33319443 — intervention group
Group type: EXPERIMENTAL
Intervention: Mamma Mia
Number of subjects: 1950
Study 33319443 — intervention group
Group type: EXPERIMENTAL
Intervention: Mamma Mia Plus
Number of subjects: 1950
Study 33319443 — intervention group
Group type: COMPARATOR
Intervention: Usual prenatal/postpartum care
Number of subjects: 1950
Study 33017434 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% enteral nutrition (EN)
Number of subjects: 6
Study 33017434 — intervention group
Group type: COMPARATOR
Intervention: 50% enteral nutrition (EN)
Number of subjects: 6
Study 35387577 — intervention group
Group type: EXPERIMENTAL
Intervention: NIATx strategy (Cohort 1, n=25)
Number of subjects: 49
Study 35387577 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (Cohort 2, n=24)
Number of subjects: 49
Study 34511513 — intervention group
Group type: EXPERIMENTAL
Intervention: HiBalance program (cognitively demanding balance and gait training)
Number of subjects: 95
Study 34511513 — intervention group
Group type: COMPARATOR
Intervention: Active control speech training program
Number of subjects: 95
Study 32077207 — intervention group
Group type: EXPERIMENTAL
Intervention: Temelimab 6 mg/kg
Number of subjects: 64
Study 32077207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 35149854 — intervention group
Group type: EXPERIMENTAL
Intervention: IXA + BEV
Number of subjects: 76
Study 35149854 — intervention group
Group type: COMPARATOR
Intervention: IXA
Number of subjects: 76
Study 33626033 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder elevation group using the inhibition method (the unaffected hand assists the affected shoulder to elevate above 90°)
Number of subjects: 60
Study 33626033 — intervention group
Group type: COMPARATOR
Intervention: Back group (the unaffected hand assists the affected upper limb in the low back and keeps it in an extended position)
Number of subjects: 60
Study 33626033 — intervention group
Group type: COMPARATOR
Intervention: Control group (no upper limb intervention)
Number of subjects: 60
Study 35351406 — intervention group
Group type: EXPERIMENTAL
Intervention: Video education about the Genetic Information Nondiscrimination Act
Number of subjects: 160
Study 35351406 — intervention group
Group type: COMPARATOR
Intervention: Control group (infographic about cell-free DNA only)
Number of subjects: 160
Study 33006003 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Therapy
Number of subjects: 102
Study 33006003 — intervention group
Group type: EXPERIMENTAL
Intervention: Short‐Term Psychoanalytic Psychotherapy
Number of subjects: 102
Study 33006003 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Psychosocial Intervention
Number of subjects: 102
Study 35687900 — intervention group
Group type: EXPERIMENTAL
Intervention: NavSTAR patient navigation intervention
Number of subjects: 0
Study 35687900 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 0
Study 33235040 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous pinning
Number of subjects: 0
Study 33235040 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation
Number of subjects: 0
Study 33235040 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plates
Number of subjects: 0
Study 33235040 — intervention group
Group type: EXPERIMENTAL
Intervention: Casting
Number of subjects: 0
Study 33235040 — intervention group
Group type: COMPARATOR
Intervention: Volar locking plate
Number of subjects: 0
Study 34003568 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy regimen (hydrocortisone 50 mg/6-h IV for 7 days, vitamin C 1.5 g/6-h IV for 4 days, thiamine 200 mg/12-h IV for 4 days)
Number of subjects: 94
Study 34003568 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone monotherapy (hydrocortisone 50 mg/6-h IV for 7 days)
Number of subjects: 94
Study 34003568 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy regimen
Number of subjects: 94
Study 34003568 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone monotherapy
Number of subjects: 94
Study 34791973 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training combined with clinical Pilates exercises (CPE)
Number of subjects: 28
Study 34791973 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training alone
Number of subjects: 28
Study 33534617 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitafloxacin 100 mg qd
Number of subjects: 343
Study 33534617 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitafloxacin 100 mg bid
Number of subjects: 343
Study 33534617 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg qd
Number of subjects: 343
Study 35339694 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium-based infiltrate
Number of subjects: 44
Study 35339694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine infiltrate
Number of subjects: 44
Study 35339694 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 44
Study 34391281 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular stimulation (IMS) to the pronator teres muscle, depth of 45-50 mm, 7 treatments over 7 weeks
Number of subjects: 75
Study 34391281 — intervention group
Group type: COMPARATOR
Intervention: Control group received acupuncture needle at Li11, depth of 4-5 mm, 7 treatments over 7 weeks
Number of subjects: 75
Study 32223567 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI with sirolimus-eluting stents
Number of subjects: 600
Study 32223567 — intervention group
Group type: COMPARATOR
Intervention: CABG
Number of subjects: 600
Study 35964335 — intervention group
Group type: EXPERIMENTAL
Intervention: W1 (orthotic wedges with foot assessment technique 1)
Number of subjects: 35
Study 35964335 — intervention group
Group type: EXPERIMENTAL
Intervention: W2 (orthotic wedges from a new assessment technique)
Number of subjects: 35
Study 35964335 — intervention group
Group type: COMPARATOR
Intervention: W1
Number of subjects: 35
Study 35964335 — intervention group
Group type: COMPARATOR
Intervention: Shod (control condition)
Number of subjects: 35
Study 34520881 — intervention group
Group type: EXPERIMENTAL
Intervention: One application of 6% hydrogen peroxide with nitrogen TiO2 nanoparticles for 72 minutes
Number of subjects: 27
Study 34520881 — intervention group
Group type: EXPERIMENTAL
Intervention: Two applications of 6% hydrogen peroxide with nitrogen TiO2 nanoparticles for 36 minutes each
Number of subjects: 27
Study 35318791 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed preparation containing piperine, capsaicin, and curcumin, applied topically twice daily for 3 months.
Number of subjects: 60
Study 35318791 — intervention group
Group type: COMPARATOR
Intervention: 5% minoxidil, applied topically once daily for 3 months.
Number of subjects: 60
Study 34806608 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver-focused group (Cg)
Number of subjects: 50
Study 34806608 — intervention group
Group type: COMPARATOR
Intervention: Patient-focused group (Pg)
Number of subjects: 50
Study 34785697 — intervention group
Group type: COMPARATOR
Intervention: 20% O2 (group A)
Number of subjects: 773
Study 34785697 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% O2 (group B)
Number of subjects: 773
Study 34785697 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% O2 until Day 6 (group B')
Number of subjects: 773
Study 34785697 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to 20% O2 from Day 2 to Day 6 (group C)
Number of subjects: 773
Study 32059078 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L crosswalk
Number of subjects: 0
Study 32059078 — intervention group
Group type: COMPARATOR
Intervention: 5L value set
Number of subjects: 0
Study 32059078 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental QALYs
Number of subjects: 0
Study 32059078 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability of cost-effectiveness
Number of subjects: 0
Study 35975663 — intervention group
Group type: EXPERIMENTAL
Intervention: Real RS‐tDCS
Number of subjects: 26
Study 35975663 — intervention group
Group type: COMPARATOR
Intervention: Sham RS‐tDCS
Number of subjects: 26
Study 32542733 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigilanol tiglate (TT) 1 mg/mL injected intratumorally
Number of subjects: 123
Study 32542733 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigilanol tiglate (TT) after retreatment
Number of subjects: 123
Study 32542733 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 123
Study 32762030 — intervention group
Group type: EXPERIMENTAL
Intervention: Silybum marianum extract (400 mg/d)
Number of subjects: 80
Study 32762030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32816564 — intervention group
Group type: EXPERIMENTAL
Intervention: AIM HI training condition
Number of subjects: 189
Study 32816564 — intervention group
Group type: COMPARATOR
Intervention: Usual Care condition
Number of subjects: 189
Study 32298428 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of adapted WHO PEN guidelines and structured training for health workers
Number of subjects: 1174
Study 32298428 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1174
Study 33221096 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded spurs combined with posterior build-ups
Number of subjects: 49
Study 33221096 — intervention group
Group type: COMPARATOR
Intervention: Conventional bonded spurs
Number of subjects: 49
Study 33045501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (50 mg orally every 8 hours during labor)
Number of subjects: 300
Study 33045501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 33045501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate
Number of subjects: 300
Study 35752091 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 mg/ml e‐cigarette
Number of subjects: 520
Study 35752091 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg/ml e‐cigarette
Number of subjects: 520
Study 35752091 — intervention group
Group type: EXPERIMENTAL
Intervention: 0 mg/ml e‐cigarette
Number of subjects: 520
Study 35752091 — intervention group
Group type: COMPARATOR
Intervention: Cigarette-substitute (CS)
Number of subjects: 520
Study 35752091 — intervention group
Group type: EXPERIMENTAL
Intervention: Total nicotine exposure
Number of subjects: 520
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate fruit and vegetable intakes
Number of subjects: 27497
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumed carbonated soft drinks at least once a day
Number of subjects: 27497
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumed fast food at least three days/week
Number of subjects: 27497
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behavior
Number of subjects: 27497
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Current E-cigarette users
Number of subjects: 27497
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Ever/current alcohol drinkers
Number of subjects: 27497
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents from urban schools
Number of subjects: 27497
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents of higher school grade
Number of subjects: 27497
Study 33383635 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents whose parents are married but living apart
Number of subjects: 27497
Study 32738662 — intervention group
Group type: EXPERIMENTAL
Intervention: iApp group (immediate-use group)
Number of subjects: 50
Study 32738662 — intervention group
Group type: COMPARATOR
Intervention: dApp group (delayed-use group)
Number of subjects: 50
Study 36228453 — intervention group
Group type: EXPERIMENTAL
Intervention: ISP group received bilateral ultrasound guided ISP block at the level of C5 using 20 ml bupivacaine 0.25% on each side
Number of subjects: 60
Study 36228453 — intervention group
Group type: EXPERIMENTAL
Intervention: ISP group
Number of subjects: 60
Study 35698124 — intervention group
Group type: EXPERIMENTAL
Intervention: Group acupuncture (AP)
Number of subjects: 11
Study 35698124 — intervention group
Group type: COMPARATOR
Intervention: Individual acupuncture (AP)
Number of subjects: 11
Study 33729664 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 52
Study 33729664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52